This is the second accelerated approval the FDA has granted to Bristol Myers Squibb’s chimeric antigen receptor T-cell ...

FDA has given accelerated approval for lisocabtagene maraleucel (liso-cel; Breyanzi) for patients with relapsed or refractory ...

Committees often have about as much utility as ashtrays on motorcycles, and in golf usually serve only as a mechanism to ...

Hepatocellular carcinoma screening was associated with earlier detection and improved survival, even after accounting for ...

Rothkopf, memorable as the painfully shy Laura Wingfield in Bridge Street’s October production of “The Glass Menagerie,” ...

Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval ...

PRESS RELEASEAB SCIENCE ANNOUNCES ISSUANCE OF A EUROPEAN PATENT FOR MASITINIB IN THE TREATMENT OF SEVERE MASTOCYTOSIS WITH PROTECTION UNTIL ...

If the student-led protests achieve nothing politically in the U.S., they have at least given hope to the hundreds of ...

A strange thing happened a few years ago when Christine Longnecker, who teaches horseback riding in and around Erie County, ...

Stephens started coverage of Blueprint Medicines (BPMC) with a buy rating and a place on its best idea list, citing the company's Ayvakit franchise. Read more here.

First data for the SC arm: 1 complete response (CR), 2 partial response (PR), 1 stable disease (SD) out of 4 evaluable ...

There is no indolent retirement waiting at the end of PM Lee's 20-year premiership. In a pair of wide-ranging interviews in ...